Your browser doesn't support javascript.
loading
SARS-CoV-2 Screening Test for Japanese Returnees From Wuhan, China, January 2020.
Kutsuna, Satoshi; Suzuki, Tadaki; Hayakawa, Kayoko; Tsuzuki, Shinya; Asai, Yusuke; Suzuki, Tetsuya; Ide, Satoshi; Nakamura, Keiji; Moriyama, Yuki; Kinoshita, Noriko; Hosokawa, Naoto; Osawa, Ryosuke; Yamamuro, Ryosuke; Akiyama, Yutaro; Miyazato, Yusuke; Nomoto, Hidetoshi; Nakamoto, Takato; Ota, Masayuki; Saito, Sho; Ishikane, Masahiro; Morioka, Shinichiro; Yamamoto, Kei; Ujiie, Mugen; Terada, Mari; Nakamura-Uchiyama, Fukumi; Sahara, Toshinori; Sano, Masahiro; Imamura, Akifumi; Sekiya, Noritaka; Fukushima, Kazuaki; Kawana, Akihiko; Fujikura, Yuji; Sano, Tomoya; Suematsu, Ryohei; Sakamoto, Naoya; Nagata, Kaoru; Kato, Tomoyuki; Katano, Harutaka; Wakita, Takaji; Sugiyama, Haruhito; Kokudo, Norihiro; Ohmagari, Norio.
Afiliação
  • Kutsuna S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Suzuki T; COVID-19 NIID Evacuation Flight Laboratory Testing Team (NEFLATT), National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
  • Hayakawa K; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Tsuzuki S; AMR Clinical Reference Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Asai Y; AMR Clinical Reference Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Suzuki T; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Ide S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Nakamura K; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Moriyama Y; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Kinoshita N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Hosokawa N; Department of Infectious Disease, Kameda Medical Center, Kamogawa City, Chiba, Japan.
  • Osawa R; Department of Infectious Disease, Kameda Medical Center, Kamogawa City, Chiba, Japan.
  • Yamamuro R; Department of Infectious Disease, Kameda Medical Center, Kamogawa City, Chiba, Japan.
  • Akiyama Y; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Miyazato Y; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Nomoto H; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Nakamoto T; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Ota M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Saito S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Ishikane M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Morioka S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Yamamoto K; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Ujiie M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Terada M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Nakamura-Uchiyama F; Department of Infectious Diseases, Ebara Hospital, Tokyo Metropolitan Health and Hospitals Corporation, Ota-ku, Tokyo, Japan.
  • Sahara T; Department of Infectious Diseases, Ebara Hospital, Tokyo Metropolitan Health and Hospitals Corporation, Ota-ku, Tokyo, Japan.
  • Sano M; Department of Infectious Diseases, Toshima Hospital, Tokyo Metropolitan Health and Hospitals Corporation, Itabashi-ku, Tokyo, Japan.
  • Imamura A; Department of Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
  • Sekiya N; Department of Infection Prevention and Control, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
  • Fukushima K; Department of Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
  • Kawana A; Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, Tokorozawa City, Saitama, Japan.
  • Fujikura Y; Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, Tokorozawa City, Saitama, Japan.
  • Sano T; Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, Tokorozawa City, Saitama, Japan.
  • Suematsu R; Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, Tokorozawa City, Saitama, Japan.
  • Sakamoto N; Department of Infectious Diseases, Tokyo Metropolitan Bokutoh General Hospital, Sumida-ku, Tokyo, Japan.
  • Nagata K; Japanese Red Cross Musashino Hospital, Musashino City, Tokyo, Japan.
  • Kato T; Japanese Red Cross Musashino Hospital, Musashino City, Tokyo, Japan.
  • Katano H; COVID-19 NIID Evacuation Flight Laboratory Testing Team (NEFLATT), National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
  • Wakita T; COVID-19 NIID Evacuation Flight Laboratory Testing Team (NEFLATT), National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
  • Sugiyama H; National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Kokudo N; National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
Open Forum Infect Dis ; 7(7): ofaa243, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32754627
ABSTRACT

BACKGROUND:

Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) was found to be the causative microorganism of coronavirus disease 2019 (COVID-19), which started to spread in Wuhan, China. This study was to evaluate the effectiveness of questionnaire, symptoms-based screening, and polymerase chain reaction (PCR) screening of returnees from COVID-19-endemic areas on a chartered flight, to examine the proportion of infected persons and the proportion of asymptomatic persons among infected persons who returned from Wuhan.

METHODS:

A retrospective cohort study was done in 7 tertiary medical institutions in Japan. A total of 566 Japanese who returned from Wuhan participated in the study.

RESULTS:

Overall, 11 of the 566 passengers had a positive SARS-CoV-2 PCR result for pharyngeal swabs and 6 were asymptomatic. Only fever differed between SARS-CoV-2-positive and -negative individuals (P < .043). Six of the 11 PCR-positive individuals were asymptomatic; 4 remained positive on day 10, and 1 asymptomatic person tested positive up to day 27. Two of the 11 were negative on the first PCR test and positive on the second.

CONCLUSIONS:

Our results will be important insights on screening returnees from locked-down cities, as well as providing important data on the proportion of asymptomatic individuals infected with SARS-CoV-2. A 13-day observation period and a second round of PCR may be effective to screen patients, including asymptomatic infections.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article